BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9396660)

  • 1. Tumor immunology.
    Shu S; Plautz GE; Krauss JC; Chang AE
    JAMA; 1997 Dec; 278(22):1972-81. PubMed ID: 9396660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigens recognized by T lymphocytes.
    Boon T; Cerottini JC; Van den Eynde B; van der Bruggen P; Van Pel A
    Annu Rev Immunol; 1994; 12():337-65. PubMed ID: 8011285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
    Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
    Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using monoclonal antibodies to stimulate antitumor cellular immunity.
    Durrant LG; Pudney VA; Spendlove I
    Expert Rev Vaccines; 2011 Jul; 10(7):1093-106. PubMed ID: 21806402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel costimulators in the immune gene therapy of cancer.
    Galea-Lauri J; Farzaneh F; Gäken J
    Cancer Gene Ther; 1996; 3(3):202-14. PubMed ID: 8725885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New possibilities for cancer therapy with advances in cancer immunology.
    MacLean GD; Longenecker BM
    Can J Oncol; 1994 Apr; 4(2):249-54. PubMed ID: 7516257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Links between genetics and immunology: mutations and antigens.
    Ayyoub M
    Bull Acad Natl Med; 2016 Jan; 200(1):67-79. PubMed ID: 29889414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor antigens and tumor vaccines: peptides as immunogens.
    Slingluff CL
    Semin Surg Oncol; 1996; 12(6):446-53. PubMed ID: 8914209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting neoantigens to augment antitumour immunity.
    Yarchoan M; Johnson BA; Lutz ER; Laheru DA; Jaffee EM
    Nat Rev Cancer; 2017 Apr; 17(4):209-222. PubMed ID: 28233802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.
    Hwang I; Nguyen N
    Arch Pharm Res; 2015 Aug; 38(8):1415-33. PubMed ID: 25634101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of new cancer therapies based on the molecular identification of cancer regression antigens.
    Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):90-100. PubMed ID: 9166458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].
    Ikeda H; Shiku H
    Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.